Skip to main content
. 2022 Apr 19;33(7-8):432–441. doi: 10.1089/hum.2021.287

Figure 1.

Figure 1.

Seropositivity for (A) the global population, (B) using the global HA weighted average, and by country for (C) AAV2, (D) AAV5, (E) AAV6, (F) AAV8, and (G) AAVrh10. Data are for adults and adolescents on day 1. Samples from Brazil were only tested using the AAV5 assay, not RUO assays. Global HA weighted average was calculated by multiplying the percentage of participants who tested positive in each country by the number of people with HA in that country, per 2018 WFH survey, divided by the total number of people with HA in all countries in this study, per 2018 WFH survey. AAV, adeno-associated virus; CI, confidence interval; HA, hemophilia A; RUO, research-use-only; WFH, World Federation of Hemophilia.